EP Patent

EP0259749B1 — Darreichungs- und Dosierungsform für Arzneimittelwirkstoffe, Reagentien oder dergleichen sowie Verfahren zu deren Herstellung

Assigned to LTS Lohmann Therapie Systeme AG · Expires 1991-08-14 · 35y expired

What this patent protects

Patent listed against apomorphine-hydrochloride.

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0259749B1
Jurisdiction: EP
Classification: —
Expires: 1991-08-14
Drug substance claim: No
Drug product claim: No
Assignee: LTS Lohmann Therapie Systeme AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.